Period:

End of Day 1 Minute 5 Minute 10 Minute 15 Minute 30 Minute Hourly Weekly Monthly Yearly

NASDAQ, NVAX - Novavax Inc

This Annual Report on Form 10-K contains forward-looking statements, within the  meaning of the Private Securities Litigation Reform Act that involve risks and  uncertainties. In some cases, forward-looking statements are identified by words  such as ?believe,? ?anticipate,? ?intend,? ?plan,? ?will,? ?may? and similar  expressions. You should not place undue reliance on these forward-looking  statements, which speak only as of the date of this report. All of these  forward-looking statements are based on information available to us at this  time, and we assume no obligation to update any of these statements. Actual  results could differ from those projected in these forward-looking statements as  a result of many factors, including those identified in the section titled ?Risk  Factors,? ?Management?s Discussion and Analysis of Financial Condition and  Results of Operations? and elsewhere.  ...

Read SEC Filing on NASDAQ.com »

Sector:	Health Care
Industry:	Biotechnology: Biological Products (No Diagnostic Substances)
P/E Ratio:	N/A
PEG Ratio:	N/A
EPS:	N/A
DivYield:	N/A
PtB:	N/A
PtS:	13.78
EBITDA:	N/A
Shares:	289.90M
Market Cap:	28.48B
52wk range:	3.54 - 111.77